Search Within

Andrew Michael Intlekofer

  1. "2024"
Formats
  1. Research Letter (2)
  2. Journal Article (1)
  3. Meeting Abstract (1)
Groups
  1. Center for Hematologic Malignancies (4)
  2. Department of Medicine (4)
  3. GSK Faculty (4)
  4. Hematologic Malignancies Research (4)
  5. Hematologic Malignancies, Division of (4)
  6. Human Oncology and Pathogenesis Program (4)

More Groups

People
  1. Alison Moskowitz (3)
  2. Anita Kumar (3)
  3. Ariela Noy (3)
  4. Gilles Salles (3)
  5. Jennifer Lue (3)
  6. Lorenzo Falchi (3)

More People

Years
  1. 2024 (4)
Publications
  1. Blood (1)
  2. Blood Cancer Journal (1)
  3. Cellular & Molecular Immunology (1)
  4. Haematologica (1)
Publishers
  1. Nature Publishing Group (2)
  2. American Society of Hematology (1)
  3. Ferrata Storti Foundation (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
    Research Letter

    Lue, J. K.; Luttwak, E.; Rivas-Delgado, A.; Irawan, H.; Boardman, A.; Caron, P. C.; David, K.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis
    Research Letter

    Johnson, W. T.; Epstein-Peterson, Z. D.; Ganesan, N.; Pak, T.; Chang, T.; Dao, P.; Moskowitz, A. J.; Stuver, R. N.; Ghione, P.; Galasso, N.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • CD8+ T cell metabolic flexibility elicited by CD28-ARS2 axis-driven alternative splicing of PKM supports antitumor immunity
    Journal Article

    Holling, G. A.; Chavel, C. A.; Sharda, A. P.; Lieberman, M. M.; James, C. M.; Lightman, S. M.; Tong, J. H.; Qiao, G.; Emmons, T. R.; Giridharan, T.; more...
    Cellular & Molecular Immunology (2024)

    Fulltext@MSK | Save